Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells

Cancer Research

Volumn 58, Issue 2, 1998, Pages 362-366

  Sheng, Hongmiao ^a   Shao, Jinyi ^a   Morrow, Jason D ^a   Beauchamp, R Daniel ^a,b   DuBois, Raymond N ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; ONCOPROTEIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE 2; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER PREVENTION; CLONOGENESIS; COLON CANCER; ENZYME INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; INTESTINE EPITHELIUM; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; XENOGRAFT;

ANIMALS; APOPTOSIS; CLONE CELLS; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOBLOTTING; ISOENZYMES; MEMBRANE PROTEINS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRAZOLES; STEM CELLS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0031984810     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. DuBois, R. N., Giardiello, F. M., and Smalley, W. E. Nonsteroidal anti-inflammatory drugs, eicosanoids and colorectal cancer prevention. Gastroenterol. Clin. North Am., 25: 773-791, 1996.
2. Portanova, J. P., Zhang, Y., Anderson, G. D., Hauser, S. D., Masferrer, J. L., Seibert, K., Gregory, S. A., and Isakson, P. C. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med., 184: 883-891, 1996.
3. Bennett, A., Del Tacca, M., Stamford, I. F., and Zebro, T. Prostaglandins from tumours of human large bowel. Br. J. Surg., 35: 882-884, 1977.
4. Bennett, A., Civier, A., Hensby, C. N., Melhuish, P. B., and Stamford, I. F. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut, 28: 315-318, 1987.
5. Lange, K., Simmet, T., Peskar, B. M., and Peskar, B. A. Determination of 15-keto-13,14-dihydro-prostaglandin E2 and prostaglandin D2 in human colonic tissue using a chemiluminescence enzyme immunoassay with catalase as labeling enzyme. Adv. Prostaglandin Thromboxane Leukotriene Res., 15: 35-38, 1985.
6. Maxwell, W. J., Kelleher, D, Keating, J. J., Hogan, F. P., Bloomfield, F. J., MacDonald, G. S., and Keeling, P. W. N. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Digestion, 47: 160-166, 1990.
7. Rigas, B., Goldman, I. S., and Levine, L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med., 122: 518-523, 1993.
8. Williams, C. W., and DuBois, R. N. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol., 270: G393-G400, 1996.
9. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
10. Kutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., and Prescott, S. M. Prostaglandin H synthase-2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA, 93: 4816-4820, 1996.
11. Kargman, S., O'Neill, G., Vickers, P., Evans, J., Mancini, J., and Jothy, S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55: 2556-2559, 1995.
12. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995.
13. Williams, C. W., Luongo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L. B., Beauchamp, R. D., and DuBois, R. N. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 111: 1134-1140, 1996.
14. 716 knockout mice by inhibition of prostaglandin endoperoxide synthase-2 (COX-2). Cell, 87: 803-809, 1996.
15. DuBois, R. N., Radhika, A., Reddy, B. S., and Entingh, A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110: 1259-1262, 1996.
16. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell, 83: 493-501, 1995.
17. Reddy, B. S., Rao, C. V., and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56: 4566-4569, 1996.
18. Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R., Morrow, J., Beauchamp, R. D., and DuBois, R. N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest., 99: 2254-2259, 1997.
19. DuBois, R. N., Awad, J., Morrow, J., Roberts, L. J., and Bishop, P. R. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Invest., 93: 493-498, 1994.
20. DuBois, R. N., Tsujii, M., Bishop, P., Awad, J. A., Makita, K., and Lanahan, A. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am. J. Physiol., 266: G822-G827, 1994.
21. Herschman, H. R. Prostaglandin synthase 2. Biochim. Biophys. Acta, 1299: 125-140, 1996.
22. Simmons, D. L., Levy, D. B., Yannoni, Y., and Erikson, R. L. Identification of a phorbol ester-repressible v-src-inducible gene. Proc. Natl. Acad. Sci. USA, 86: 1178-1182, 1989.
23. Coffey, R. J., Hawkey, C. J., Damstrup, L., Graves-Deal, R., Daniel, V. C., Dempsey, P. J., DuBois, R. N., Jetton, T., and Morrow, J. EGF receptor activation induces nuclear targeting of COX-2, basolateral release of prostaglandins and mitogenesis in polarizing colon cancer cells. Proc. Natl. Acad. Sci. USA, 94: 657-662, 1997.
24. Marsh, K. A., Stamp, G. W., and Kirkland, S. C. Isolation and characterization of multiple cell types from a single human colonic carcinoma: tumourigenicity of these cell types in a xenograft system. J. Pathol., 170: 441-450, 1993.
25. Groden, J., Joslyn, G., Samowitz, W., Jones, D., Bhattacharyya, N., Spirio, L., Thliveris, A., Robertson, M., Egan, S., Meuth, M., and White, R. Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res., 55: 1531-1539, 1995.
26. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., and Saltiel, A. R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270: 27489-27494, 1995.
27. 1 delay in intestinal epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res., 56: 733-737, 1996.
28. Heidenreich, S., Otte, B., Lang, D., and Schmidt, M. Infection by Candida albicans inhibits apoptosis of human monocytes and monocytic U937 cells. J. Leukocyte Biol., 60: 737-743, 1996.
29. Rossi, A. G., Cousin, J. M., Dransfield, I., Lawson, M. P., Chilvers, E. R., and Haslett, C. Agents that elevate cAMP inhibit human neutrophil apoptosis. Biochem. Biophys. Res. Commun., 217: 892-899, 1995.
30. Brown, D. M., and Phipps, R. P. Bcl-2 expression inhibits prostaglandin E2-mediated apoptosis in B cell lymphomas. J. Immunol., 157: 1359-1370, 1996.
31. Pritchard, D. M., and Watson, A. J. M. Apoptosis and gastrointestinal pharmacology. Pharmacol. Ther., 72: 149-169, 1996.
32. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
33. Nakamura, Y., Nishisho, I., Kinzler, K. W., Vogelstein, B., Miyoshi, Y., Miki, Y., Ando, H., and Horii, A. Mutations of the APC (adenomatous polyposis coli) gene in FAP (familial polyposis coli) patients and in sporadic colorectal tumors. Tohoku J. Exp. Med., 168: 141-147, 1992.